Outcomes of older adults and frail patients receiving idecabtagene vicleucel: A CIBMTR study Research Letter

   

Authors:	Akhtar, O. S.; Oloyede, T.; Brazauskas, R.; Afrough, A.; Hashmi, H.; Sidana, S.; Ahmed, N.; Bye, M.; Hansen, D.; Ferreri, C.; Dhakal, B.; Dhanda, D.; Harrison, M.; Kitali, A.; Landau, H.; Mirza, A. S.; Patel, J.; Patwardhan, P.; Qazilbash, M.; Patel, K.; Nishihori, T.; Ganguly, S.; Gowda, L.; Anderson, L. D. Jr; Pasquini, M. C.; Usmani, S.; Freeman, C. L.
Title:	Outcomes of older adults and frail patients receiving idecabtagene vicleucel: A CIBMTR study
Keywords:	adult; aged; major clinical study; overall survival; mortality; neurotoxicity; outcome assessment; follow up; letter; progression free survival; relapse; retrospective study; risk factor; confidence interval; hospitalization; hazard ratio; cytokine release syndrome; frailty; very elderly; human; male; female; idecabtagene vicleucel
Journal Title:	Blood Advances
Volume:	9
Issue:	7
ISSN:	2473-9529
Publisher:	American Society of Hematology
Date Published:	2025-04-08
Start Page:	1587
End Page:	1592
Language:	English
DOI:	10.1182/bloodadvances.2024014970
PUBMED:	39786391
PROVIDER:	scopus
PMCID:	PMC11986210
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-105002032521&doi=10.1182%2fbloodadvances.2024014970&partnerID=40&md5=b42a8d78148c8b5f0cba4e71483ad9c8
Notes:	Letter -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/224564